Zhejiang University will co-establish the Zhesfon Pharmaceutical Research Center with 'Soli Pharmaceutical (300181.SZ)'

Financial news from the Securities Times app, Zall Pharmaceutical (300181.SZ) announced that the company recently signed a "Zhejiang University-Zall Pharmaceutical Smart Empowerment Food and Drug Joint Research and Development Center Construction Agreement" and a "Technology Development (Commission) Contract" with Zhejiang University. The company plans to invest a total of 20 million yuan in the above two agreements.